How reliable is conventional urinary cytology in post-transplant patients?

Urologia Internationalis

Volumn 71, Issue 2, 2003, Pages 176-177

  Reichelt, Olaf ^a   Wunderlich, Heiko ^a   Neiser, Grit ^a   Schubert, Jörg ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Bladder cancer; Cytology; Renal transplantation

Indexed keywords

CREATININE; IMMUNOLOGIC AGENT;

ADULT; AGED; ARTICLE; BRIGHT FIELD MICROSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE CLASSIFICATION; DIURESIS; FEMALE; FOLLOW UP; HUMAN; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MALE; MALIGNANT TRANSFORMATION; MICROSCOPY; PAPANICOLAOU TEST; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TUMOR PROMOTION; URINE CYTOLOGY; URINE SEDIMENT; UROTHELIUM;

CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; URINE; UROLOGIC NEOPLASMS;

EID: 0041743767     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071842     Document Type: Article

References (5)

1. Britton JP: Effectiveness of haematuria clinics. Br J Urol 1993;71:247-252.
2. Schwalb DM, Herr HW, Fair WR: The management of clinically unconfirmed positive cytology. J Urol 1993;150:1751-1756.
3. Koshikawa T, Leyh H, Schenck U: Difficulties in evaluating urinary specimens after local mitomycin therapy of bladder cancer. Diagn Cytopathol 1989;5:117-121.
4. Chahal R, Gogoi NK, Sundaram SK: Is it necessary to perform urine cytology in screening patients with haematuria? Eur Urol 2001;39: 283-286.
5. Kyllonen L, Pukkala E, Eklund B: Cancer incidence in a kidney-transplanted population. Transpl Int 1994;7:S350-S352.